Article ; Online: Treatment outcomes of PCR-positive acute retinal necrosis.
Irish journal of medical science
2023 Volume 193, Issue 1, Page(s) 509–516
Abstract: Background: Acute retinal necrosis (ARN) is a progressive necrotizing retinitis caused by viral infection. Optimal management strategies have not been established for this detrimental disease. Previous literature published suggests that Varicella-zoster ...
Abstract | Background: Acute retinal necrosis (ARN) is a progressive necrotizing retinitis caused by viral infection. Optimal management strategies have not been established for this detrimental disease. Previous literature published suggests that Varicella-zoster virus (VZV) and Herpes simplex virus-1 (HSV1) are the most common promoters of acute retinal necrosis (ARN). Aims: The purpose of our study was to investigate the viral distribution, demographic, and treatment outcomes of ARN. Methods: A retrospective chart review evaluated data from PCR-positive ARN patients diagnosed between 2009 and 2018. Results: Analysis of fourteen eyes from 12 patients found CMV and VZV as the commonest causes of ARN. Patients on 1 g of valacyclovir three times a day (V1T) had worse vision between first and final visits (mean difference of 1.25 ± 0.65, n = 2) compared with patients treated with 2 g of valacyclovir three times a day (V2T), or 900 mg twice a day of valganciclovir (V9B) (mean difference of - 0.067 ± 0.13, n = 6, and 0.067 ± 0.067, n = 6, respectively). Both V1T patients developed retinal detachments (RD). Both CMV patients treated with intravitreal triamcinolone developed ARN, elevated IOP, and one developed multiple RD. Conclusions: Our review found increased incidence of CMV-positive ARN. Patients with zone 1 disease had worse initial visual acuity. Moreover, patients had more favorable outcomes with V2T and V9B compared to V1T. CMV-positive patients clinically worsened after intravitreal steroid injections, further underscoring the value of a PCR diagnosis to tailor the patients' treatment plan accordingly. |
---|---|
MeSH term(s) | Humans ; Retinal Necrosis Syndrome, Acute/diagnosis ; Retinal Necrosis Syndrome, Acute/etiology ; Valacyclovir ; Retrospective Studies ; Herpesvirus 3, Human/genetics ; Retinal Detachment ; Treatment Outcome ; Polymerase Chain Reaction ; Cytomegalovirus Infections/complications |
Chemical Substances | Valacyclovir (MZ1IW7Q79D) |
Language | English |
Publishing date | 2023-06-27 |
Publishing country | Ireland |
Document type | Review ; Journal Article |
ZDB-ID | 390895-1 |
ISSN | 1863-4362 ; 0021-1265 |
ISSN (online) | 1863-4362 |
ISSN | 0021-1265 |
DOI | 10.1007/s11845-023-03426-2 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 323: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.